Ms Kat Bogatyreva

Excess all-cause mortality and COVID-19-related mortality: a temporal analysis in 22 countries, from January until August 2020

S Achilleos, A Quattrocchi, J Gabel, A Heraclides, O Kolokotroni, C Constantinou, M Ugarte, N Nicolaou, J Rodriguez-Llanes, C Bennett, E Bogatyreva, E Schernhammer, C Zimmermann, A Costa, J Lobato, N Fernandes, A Semedo-Aguiar, G Ramirez, O Garzon, L Mortensen, J Critchley, L Goldsmith, G Denissov, K Rüütel, N Le Meur, L Kandelaki, S Tsiklauri, J O’Donnell, A Oza, Z Kaufman, I Zucker, G Ambrosio, F Stracci, T Hagen, I Erzen, P Klepac, P González, Á Camporro, B Burström, N Pidmurniak, O Verstiuk, Q Huang, N Mehta, A Polemitis, A Charalambous, C Demetriou

(2022), Vol. 51, pp. 35-53, International Journal of Epidemiology, England, C1

A prescription for resistance: Management of staphylococcal skin abscesses by general practitioners in Australia

C Parrott, G Wood, E Bogatyreva, G Coombs, P Johnson, C Bennett

(2016), Vol. 7, Frontiers in Microbiology, Switzerland, C1

Preclinical FLT-PET and FDG-PET imaging of tumor response to the multi-targeted Aurora B kinase inhibitor, TAK-901

C Cullinane, K Waldeck, D Binns, E Bogatyreva, D Bradley, J de, G McArthur, R Hicks

(2014), Vol. 41, pp. 148-154, Nuclear medicine and biology, Amsterdam, The Netherlands, C1-1

Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models.

C Cullinane, D Dorow, S Jackson, B Solomon, E Bogatyreva, D Binns, R Young, M Arango, J Christensen, G McArthur, R Hicks

(2011), Vol. 52, pp. 1261-1267, Journal of nuclear medicine, Chicago, Il., C1-1